Ken Griffin Surmodics Inc Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Surmodics Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 500 shares of SRDX stock, worth $19,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
500
Previous 200
150.0%
Holding current value
$19,245
Previous $5,000
320.0%
% of portfolio
0.0%
Previous 0.0%
Shares
26 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
13MCall Options Held
25.5KPut Options Held
3.4K-
Beryl Capital Management LLC Redondo Beach, CA1.54MShares$59.4 Million25.28% of portfolio
-
Black Rock Inc. New York, NY1.17MShares$45.1 Million0.0% of portfolio
-
Morgan Stanley New York, NY1.12MShares$43 Million0.0% of portfolio
-
Trigran Investments, Inc.1.04MShares$40.2 Million4.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$30.9 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $539M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...